VCNX Vaccinex Inc.: Multiplikator nilai perusahaan marang pendapatan

Logo perusahaan publik vaccinex.com (VCNX)

Vaccinex, Inc. (VCNX) attracts leading clinicians through promising developments in oncology. Professional management is effectively advancing therapeutic platforms, and on GURU.Markets, this EV/Sales trajectory clearly confirms the market valuation, where the current parameter equals . The company's operations are strictly limited by FDA medical regulations, which guarantees compliance with basic environmental standards during the disposal of biomaterials.

Nilai perusahaan marang pendapatan: Vaccinex Inc. (VCNX) kanggo 04.07.2022 - 20.11.2026

vaccinex.com - rincian analitis lan metrik utama (VCNX)

- rega saham lan konsensus proyeksi valuasi:
Analisis wiwitan perusahaan:Vaccinex, Inc. VCNX
Sampel barang Vaccinex, Inc.

The market evaluates Vaccinex, Inc. (VCNX) through a lens of high risk due to liquidity shortages and frequent secondary offerings to support oncology research. By analyzing the firm's valuation via the EV/Sales multiple, an investor views the ratio of enterprise value (market capitalization plus debt minus cash) to revenue, which allows them to filter out speculative noise and determine the asset's actual fundamental stability against a backdrop of volatile sales.

Analisis pesaing Vaccinex, Inc.

IBRX (immunitybio.com) - Rasio nilai perusahaan marang pendapatan|Immunocore Corp (IMCR) - Rasio nilai perusahaan marang pendapatan|Multiplikator nilai perusahaan marang pendapatan Janux Pharma (JANX)|Nilai perusahaan marang pendapatan RCUS|ZYME - Rasio nilai perusahaan marang dodolan|Nilai perusahaan marang pendapatan TNGX (Tango Pharma)|Koefisien nilai perusahaan marang pendapatan IOVA|Multiplikator EV/Sales IMTX (Immatics)|Nilai bisnis marang pendapatan XNCR|compasstherapeutics.com - Multiplikator EV/Sales|Multiplikator nilai perusahaan marang pendapatan Replimune Inc.|Lyell Immunopharma (LYEL) - Rasio nilai perusahaan marang pendapatan|Innate Pharma S.A. - Nilai bisnis marang pendapatan|PYXS (Pyxis) - Multiplikator EV/Sales|Multiplikator EV/Sales cgen.com|Rasio nilai perusahaan marang pendapatan IO Biotech (IOBT)|STRO: Nilai perusahaan marang volume dodolan|MiNK Therapeutics Inc. - Nilai perusahaan marang pendapatan|werewolftx.com (HOWL) - Multiplikator nilai perusahaan marang pendapatan|Immix Biopharma Inc. - Multiplikator EV/Sales|ALXO - Multiplikator EV/Sales|CUE: Multiplikator EV/Sales|Rasio nilai perusahaan marang pendapatan PDSB|Rasio nilai perusahaan marang pendapatan Sonnet BioTherapeutics Holdings|MAIA Biotechnology (MAIA) - Rasio total nilai perusahaan marang pendapatan|Multiplikator EV/Sales LIMN|Multiplikator EV/Sales Lava Tx (LVTX)|Multiplikator EV/Sales NXTC (NextCure Corporation)|Nilai bisnis marang pendapatan LPTX|INTS - Rasio nilai perusahaan marang pendapatan|Rasio total nilai perusahaan marang pendapatan Sensei Biotherapeutics Inc SNSE|TOVX: Multiplikator EV/Sales|Multiplikator nilai perusahaan marang pendapatan Gritstone Bio (GRTS)|KA (Kineta Corp) - Multiplikator EV/Sales|Rasio nilai perusahaan marang pendapatan NEXI (NexImmune Corp)|Multiplikator EV/Sales TSBX|Koefisien nilai perusahaan marang pendapatan HARP